From the latest Alan Kohler interview w Eureka report, 300000 units sold in Japan represents monthly scripts for just 25000 patients.
Assuming 5% market share of 3.7 million HH sufferrers in the US is 160000 people x 12 months x $700 per script is $1.3 Billion revenue p/a. USD.
Put a P/E multiple of 15 on that and you get $20 Bil. MC USD which equates to share price north of $20 aud.
Back of the envelope but realistic inputs.
Sheesh.
Bot Chart, page-7516
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.3¢ |
Change
0.013(3.21%) |
Mkt cap ! $730.1M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 41.0¢ | 39.5¢ | $2.104M | 5.253M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 823506 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 189916 | 23 |
View Market Depth
| Last trade - 15.20pm 02/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |